Literature DB >> 16372367

Analgesic and anticonvulsant properties of Tetrapleura tetraptera (Taub) (Fabaceae) fruit aqueous extract in mice.

John A O Ojewole1.   

Abstract

Previous studies in our laboratories and elsewhere have shown that the fruit of Tetrapleura tetraptera (Taub) (family: Fabaceae) is widely used in African traditional medicine for the management and/or control of an array of human ailments, including schistosomiasis, asthma, epilepsy, hypertension and so on. The present study was designed to investigate the analgesic and anticonvulsant effects of Tetrapleura tetraptera (Taub) fruit aqueous extract (TTE) in mice. Morphine (MPN, 10 mg/kg i.p.), diclofenac (DIC, 100 mg/kg i.p.), phenobarbitone (20 mg/kg i.p.) and diazepam (0.5 mg/kg i.p.) were used, respectively, as reference analgesic and anticonvulsant agents for comparison. T. tetraptera fruit aqueous extract (TTE, 50-800 mg/kg i.p.) produced dose-dependent, significant (p < 0.05-0.001) analgesic effects against thermally and chemically induced pain in mice. Like the standard anticonvulsant agents (phenobarbitone and diazepam) used, T. tetraptera fruit aqueous extract (TTE, 50-800 mg/kg i.p.) significantly (p < 0.05-0.001) delayed the onset of, and antagonized, pentylenetetrazole (PTZ)-induced seizures. Aqueous extract of the fruit (TTE, 50-800 mg/kg i.p.) also profoundly antagonized picrotoxin (PCT)-induced seizures, but only partially and weakly antagonized bicuculline (BCL)-induced seizures. However, the results of this experimental animal study indicate that Tetrapleura tetraptera (Taub) fruit aqueous extract (TTE) possesses analgesic and anticonvulsant properties. These findings lend pharmacological support to the suggested folkloric uses of the plant's fruit in the management and/or control of painful, arthritic inflammatory conditions, as well as for the management and/or control of epilepsy and childhood convulsions in some tropical African countries. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372367     DOI: 10.1002/ptr.1779

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Anticonvulsant and Neuroprotective Effects of Paeonol in Epileptic Rats.

Authors:  Dong-Hai Liu; Elvis Agbo; Shu-Hong Zhang; Jin-Ling Zhu
Journal:  Neurochem Res       Date:  2019-09-13       Impact factor: 3.996

2.  In vitro antiplasmodial activity of crude extracts of Tetrapleura tetraptera and Copaifera religiosa.

Authors:  Jean Bernard Lekana-Douki; Sandrine Lydie Oyegue Liabagui; Jean Bernard Bongui; Rafika Zatra; Jacques Lebibi; Fousseyni S Toure-Ndouo
Journal:  BMC Res Notes       Date:  2011-11-23

Review 3.  Ethnopharmacological Survey of Plants Used in the Traditional Treatment of Gastrointestinal Pain, Inflammation and Diarrhea in Africa: Future Perspectives for Integration into Modern Medicine.

Authors:  Timo D Stark; Dorah J Mtui; Onesmo B Balemba
Journal:  Animals (Basel)       Date:  2013-03-04       Impact factor: 2.752

4.  Reduction of anoxia-induced bioenergetic disturbance in astrocytes by methanol fruit extract of Tetrapleura tetraptera and in silico evaluation of the effect of its antioxidative constituents on excitotoxicity.

Authors:  Ibrahim Olabayode Saliu; Reshma Bhagat; Olubukola Benedicta Ojo; Afolabi C Akinmoladun; M Tolulope Olaleye; Pankaj Seth; Velayudhan Rema
Journal:  Toxicol Rep       Date:  2021-01-26

5.  Anticonvulsant Activity of Hydroalcoholic Extract and Aqueous Fraction of Ebenus stellata in Mice.

Authors:  Ayeh Khodaparast; Mohammad Sayyah; Soroush Sardari
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

6.  Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana.

Authors:  Patrick Amoateng; Emmanuel Quansah; Thomas K Karikari; Alex Asase; Dorcas Osei-Safo; Kennedy Kwami Edem Kukuia; Isaac Kingsley Amponsah; Alexander K Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.